Enter your terms above and click the 'Search' button.

Showing articles 0 to 5 of 5 Filter Applied: adverse drug reaction (Click to remove) Adverse Events Associated with Disease-Modifying Drugs for Multiple Sclerosis Neurol 102:e208006, Ng, HS.,et al, 2024 Use of Newer Disease-Modifying Therapies in Pediatric Multiple Sclerosis in the US Neurol 91:e1778-e1787, Krysko, K.M.,et al, 2018 Newer Agents in the Treatment of Multiple Sclerosis Neurologist 19:104-117, Pawate, S. & Bagnato F., 2015 Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis NEJM 367:1098-1106,1149, Gold, R.,et al, 2012 Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012 Showing articles 0 to 5 of 5